The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. (Q40734041)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q57415199)
(P304) 1207-1213
(P407) (Q1860)
(P433) 9
(P478) 195
(P577) Wednesday, May 1, 2002
(P921) (Q61659151)
(P1433) (Q3186912)
(P1476) "The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound" (language: en)
(P2093) Judith Gerlach
Reinhard Brossmer
Claus-Peter Danzer
Lars Nitschke
(P2860) (Q28613809)
(Q40755330)
(Q34264039)
(Q34184901)
(Q36368171)
(Q27760602)
(Q36491551)
(Q24647368)
(Q28302610)
(Q28510573)
(Q34390099)
(Q28615950)
(Q38309269)
(Q38297303)
(Q28615693)
(Q34404844)
(Q28287516)
(Q38333338)
(Q41102926)
(Q41491797)
(Q41552480)
(Q55066830)
(Q52198671)
(Q73270989)
(Q77304184)
(Q72081838)
(Q72649147)
(Q95819022)